Breast cancer: Current and future endocrine therapies-Reference-Cited by-同舟云学术

Breast cancer: Current and future endocrine therapies

Published:2014-01 Issue:1 Volume:382 Page:695-723
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Palmieri Carlo,Patten Darren K.,Januszewski Adam,Zucchini Giorgia,Howell Sacha J.

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference275 articles.

1. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Aebi;Ann Oncol.,2011

2. In vitro characterization of ZK 230211—a type III progesterone receptor antagonist with enhanced antiproliferative properties;Afhüppe;J. Steroid Biochem. Mol. Biol.,2010

3. Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study;Alba;Ann Oncol.,2012

4. Combination of notch inhibitor MK-0752 and endocrine therapy for early stage ERα+breast cancer in a presurgical window pilot study;Albain;Cancer Res.,2010

5. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines;Alao;Clin. Cancer Res.,2004

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α;Medical Oncology;2024-08-21

2. Tetrahydroisoquinolines – an updated patent review for cancer treatment (2016 – present);Expert Opinion on Therapeutic Patents;2024-08-19

3. Design, Synthesis, In Vitro, and In Silico Studies of Some Newly Fused Thiadiazole and Thiadiazine Derivatives Incorporating 1,2,4-Triazole Derivatives as Aromatase Enzyme Inhibitor;Russian Journal of Bioorganic Chemistry;2024-08

4. Radiological and Molecular Analysis of Radioiodinated Anastrozole and Epirubicin as Innovative Radiopharmaceuticals Targeting Methylenetetrahydrofolate Dehydrogenase 2 in Solid Tumors;Pharmaceutics;2024-05-03

5. Resistance to Endocrine Therapy in Breast Cancer;Overcoming Breast Cancer Therapy Resistance;2024